Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Acromegaly

Clinical Trial Details

Overview

Research Study Summary

Patients are needed to participate in a clinical research study evaluating Alesse for the treatment of Acromegaly

Purpose

Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.

To Learn more
Phase

2

Gender

Female

Age

18 and up

Overall Status

Recruiting

Lead Sponsor

Université de Montréal

Facility Type

N/A

Eligibility

Female ages 18 Years and up

Inclusion Criteria:

  • Women 18 years and older treated with somatostatin analogs

  • Active acromegaly

Exclusion Criteria:

  • Cardiovascular or cerebrovascular disease

  • Thrombophlebitis or thromboembolism

  • Breast cancer

  • Non-controlled arterial hypertension

  • Smoking

  • Pregnancy or lactation

Site Locations (1)

Country State City Zip Facility and Contact
Canada Quebec Montreal H2L 4M1 CHUM - Notre-Dame Hospital

Omar Serri, MD
Principal Investigator

Contact

Omar SERRI, MD
514-890-8000 ext. 25607

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

NCT ID: NCT00315107

Date Last Changed: May 25, 2006

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.